205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.73%
Revenue growth at 50-75% of NXPI's 3.21%. Martin Whitman would worry about competitiveness or product relevance.
1.31%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-2.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-70.59%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.48%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-69.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-3.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.09%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.93%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-34.43%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-46.04%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
57.48%
10Y revenue/share CAGR at 50-75% of NXPI's 79.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
125.75%
5Y revenue/share CAGR above 1.5x NXPI's 77.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
69.50%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
176.00%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
39.23%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-6.21%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
581.29%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
765.91%
5Y net income/share CAGR above 1.5x NXPI's 328.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
79.28%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
194.56%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
15.59%
5Y equity/share CAGR at 75-90% of NXPI's 18.89%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
20.14%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
40.48%
Dividend/share CAGR of 40.48% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
37.98%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
41.93%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.29%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.69%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-7.18%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.02%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
6.34%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.35%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.